Complex Interventional Cardiovascular Therapy 2021

$20.00

This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!

Include: 71 videos + 1 pdf

Size: 7.52 GB

Categories: Cardiology, Courses, Internal Medicine Tag: Internal Medicine

Description

Complex Interventional Cardiovascular Therapy 2021

– 14th Annual Conference: A Case Based Workshop is organized by cme4u GmbH Congresses, Meetings and Education and will be held from Jul 16 – 17, 2021 at InterContinental Chicago Magnificent Mile, Chicago, Illinois, United States of America.

Who Should Attend:

The CICT workshops have been designed to meet the educational needs of interventional cardiologists, non-invasive cardiologists and cardiology fellows along with cath lab nurses and technicians and other medical professionals who care for patients undergoing catheter-based cardiovascular interventions.

Accreditation:

The CMEsolutions designates this live activity for a maximum of 16.75 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Description:

The goal of the CICT Conferences is to promote high quality, patient-centered, clinical and technical decision-making in the field of Interventional Cardiovascular Medicine. The uniqueness of the CICT conferences lies in the open forum transparent discussion of controversial topics allowing free flowing interaction between audience and faculty. The content of these meetings addresses a wide range of complex cardiovascular interventional topics that still present a challenge to the clinician with respect to choosing the appropriate therapy (surgery vs. catheter-based therapy) and with respect to using optimal technique to ensure the safety and efficacy of the procedure.

Learning Objectives:

Upon conclusion of this program, participants should be able to:

• Demonstrate patient-centered evidence-based decision-making at the individual patient level.
• Explain the skill set necessary to triage patients with complex coronary and structural heart disease to surgical vs. endovascular intervention.
• Discuss cognitive and technical skills to maximize success and reduce complications in complex cardiovascular interventions.
• Identify best practices to prevent and manage complications in coronary and structural heart disease interventions.
• Exercise hands-on technical training for percutaneous cardiac structural procedures.

list

CICT-2021.pdf
COMPLEX MULTIVESSEL CAD – Case conclusion Naveed Adoni, MD.mp4
COMPLEX MULTIVESSEL CAD – Case introduction A Patient with complex 3 vessel CAD (intermediate and highSYNTAX score) Naveed Adoni, MD.mp4
COMPLEX MULTIVESSEL CAD – Follow the evidence (the ISCHEMIA trial)…Try medical therapy first! Rajiv Gulati, MD, PhD.mp4
COMPLEX MULTIVESSEL CAD – In stable CAD, does complete revascularization tip the balance in favor of an invasive strategy- the ISCHEMIA Gregg Stone, MD.mp4
COMPLEX MULTIVESSEL CAD – Let’s be more nuanced.FFR guided PCIDES simplifies complexity and yields better outcome! Habib Samady, MD.mp4
COMPLEX MULTIVESSEL CAD – Q & A.mp4
COMPLEX MULTIVESSEL CAD – The evidence is clear.Old fashion CABG is associated with better survival! Aziz Ghaly, MD.mp4
HOW TO REVASCULARIZE COMPELX CTOs – How to revascularize a long LCX occlusion (40 mm) Tim Fischell, MD.mp4
HOW TO REVASCULARIZE COMPELX CTOs – How to revascularize a tortous and calcified RCA CTO Mark Ricciardi, MD.mp4
HOW TO REVASCULARIZE COMPELX CTOs – How to revascularize an ostial LAD CTO Khaldoon Alaswad, MD.mp4
HOW TO REVASCULARIZE COMPLEX SEVERELY CALCIFIED LESIONS – PCI in severely calcified and tortous RCA My first choice is orbital atherectomyCase-based presentation Ramzan Zakir, MD.mp4
HOW TO REVASCULARIZE COMPLEX SEVERELY CALCIFIED LESIONS – PCI in severely calcified CAD My first choice is still rotational atherectomy Case-based presentation Sanja Mehta, MD.mp4
HOW TO REVASCULARIZE COMPLEX SEVERELY CALCIFIED LESIONS – Shockwave balloon lithotripsy How did it change my approach to calcified lesions Case-based presentation Richard Shlofmitz.mp4
Innovations in Device-Based Heart Failure Therapy – Innovations in cardiac electrophysiologic therapeutics Ken Stein, MD.mp4
Innovations in Device-Based Heart Failure Therapy – Innovations in renal artery ablation Horst Sievert, MD.mp4
Innovations in Device-Based Heart Failure Therapy – Innovations in sensors and cardiac neuromodulation Kalyanam Shivkumar, MD.mp4
Innovations in Device-Based Heart Failure Therapy – Innovations in structural heart disease interventions Horst Sievert, MD.mp4
Innovations in Device-Based Heart Failure Therapy – Q & A.mp4
INTRAVASCULAR IMAGING MECHANISTIC INSIGHTS AND PCI OPTIMIZATION – How does Shockwave balloon lithotripsy work Insights from OCTCase-based presentation Richard Shlofmitz, MD.mp4
INTRAVASCULAR IMAGING MECHANISTIC INSIGHTS AND PCI OPTIMIZATION – How to use OCT to optimize PCI results and limit contrast use Case-based presentation Bassem Chehab, MD.mp4
INTRAVASCULAR IMAGING MECHANISTIC INSIGHTS AND PCI OPTIMIZATION – Saline OCT Why and HowCase-based presentation Evan Shlofmitz, MD.mp4
LEFT ATRIAL APPENDAGE (LAA) CLOSURE – ICE is an ideal intra procedure imaging modality Case studies Mohamad Alkhouli, MD.mp4
LEFT ATRIAL APPENDAGE (LAA) CLOSURE – Innovations for prevention of air embolism Kalyanam Shivkumar, MD.mp4
LEFT ATRIAL APPENDAGE (LAA) CLOSURE – Pivotal clinical trials of LAAC (LAAOS III trial, ect..) A critical appraisal! Randy Lee, MD.mp4
LEFT ATRIAL APPENDAGE (LAA) CLOSURE – What is the best sizing strategy Echo, angiography, CTA, 3D printing Case studies Jacqueline Saw, MD.mp4
PFO AND ASD CLOSURE – How to tailor closure device to anatomy Case studies Vaikom Mahadevan, MD.mp4
PFO AND ASD CLOSURE – PFO closure for migraine Will there be a resurrection! Jonathan Tobis, MD.mp4
PHARMACOLOGICAL AND DEVICE-BASED MANAGEMENT IN ACUTE CORONARY SYNDROMES – Genotype-Guided P2Y12 selection should be the gold standard to guide post DES antiplatelet therapy Naveen Pereira, MD.mp4
PHARMACOLOGICAL AND DEVICE-BASED MANAGEMENT IN ACUTE CORONARY SYNDROMES – I never use manual aspiration in STEMI Here is why! Giora Weisz, MD.mp4
PHARMACOLOGICAL AND DEVICE-BASED MANAGEMENT IN ACUTE CORONARY SYNDROMES – Pre-procedure Cangrelor should be utilized more often in selected patients Here is why! George Dangas, MD.mp4
PHARMACOLOGICAL AND DEVICE-BASED MANAGEMENT IN ACUTE CORONARY SYNDROMES – Pre-procedure IIbIIIa should be utilized more often in selected patients Here is why! Arnold Seto, MD.mp4
PHARMACOLOGICAL AND DEVICE-BASED MANAGEMENT IN ACUTE CORONARY SYNDROMES – The universe of post DES Ticagrelor vs. Prasugrel controversy A critical appraisal of the evidence! Roxana Mehran, MD.mp4
PHARMACOLOGICAL AND DEVICE-BASED MANAGEMENT IN ACUTE CORONARY SYNDROMES – Why I use mechanical thrombectomy with Penumbra CAT RX in acute myocardial infarction Darshan Doshi, MD.mp4
SHOULD CORONARY CTA REPLACE STRESS TESTING FOR DIAGNOSIS OF CAD – A paradigm shift is overdue! CTA -FFR is the new gold standard for initial ischemia evaluation Jonathon Leipsic, MD.mp4
SHOULD CORONARY CTA REPLACE STRESS TESTING FOR DIAGNOSIS OF CAD – Case conclusion John Blair, MD.mp4
SHOULD CORONARY CTA REPLACE STRESS TESTING FOR DIAGNOSIS OF CAD – Case presentation A diagnostic journey of a patient! John Blair, MD.mp4
SHOULD CORONARY CTA REPLACE STRESS TESTING FOR DIAGNOSIS OF CAD – CT-FFR in real life Pros and Cons! Case-Based Presentation Varinder Singh, MD.mp4
SHOULD CORONARY CTA REPLACE STRESS TESTING FOR DIAGNOSIS OF CAD – Q & A.mp4
SHOULD CORONARY CTA REPLACE STRESS TESTING FOR DIAGNOSIS OF CAD – The evidence speaks for itself Invasive FFR remains the gold standard Habib Samady, MD.mp4
STENT DESIGN AND DAPT DURATION IN PATIENTS AT HIGH BLEEDING RISK – All available 3rd generation DES are similarly effective in reducing thrombotic risk John Messenger, MD.mp4
STENT DESIGN AND DAPT DURATION IN PATIENTS AT HIGH BLEEDING RISK – Alternative access in cardiogenic shock for mechanical support devices in patients with PAD Amir Kaki, MD.mp4
STENT DESIGN AND DAPT DURATION IN PATIENTS AT HIGH BLEEDING RISK – DAPT duration in complex PCI Do the standard trials apply Jennifer Tremmel, MD.mp4
STENT DESIGN AND DAPT DURATION IN PATIENTS AT HIGH BLEEDING RISK – DAPT for 4 weeks is safe and effective Jorge Saucedo, MD.mp4
STENT DESIGN AND DAPT DURATION IN PATIENTS AT HIGH BLEEDING RISK – Does the choice of DOACs matter in patients with stable coronary artery disease George Dangas, MD.mp4
STENT DESIGN AND DAPT DURATION IN PATIENTS AT HIGH BLEEDING RISK – Protected PCI in a patient with complex CAD and severe aortic stenosis Ashok Chaudhary, MD.mp4
STENT DESIGN AND DAPT DURATION IN PATIENTS AT HIGH BLEEDING RISK – Rotational atherectomy and protected PCI in a patient with complex severely calcified CAD and reduced LVEF Giora Weisz, MD.mp4
TAVR HOW-TO WORKSHOP – How to optimize deployment of the evolute pro valveCase studies Maurice Buchbinder, MD.mp4
TAVR HOW-TO WORKSHOP – How to optimize TAVR for bicuspid aortic valve procedures Tarun Chakravarty, MD_2.mp4
TAVR HOW-TO WORKSHOP – How to optimize TAVR for valve-in-valve proceduresCase studies Ron Waksman, MD.mp4
TAVR HOW-TO WORKSHOP – How to optimize TAVR in patients with low coronary ostiaCase studies Vaikom Mahadevan, MD.mp4
TAVR HOW-TO WORKSHOP – How to optimize TAVR safely in patients with severely calcified annulus LVOT Case studies Raj Makkar, MD.mp4
TAVR HOW-TO WORKSHOP – Interventional structural electrophysiology – TAVR predicting risk of complete heart block & how to pace Kalyanam Shivkumar, MD.mp4
TAVR HOW-TO WORKSHOP – Optimizing difficult iliofemoral access in patients with severe iliac disease role of lithotripsy and covered stentsCase st.mp4
TRANSCATHETER MITRAL VALVE REPAIR REPLACEMENT – How to tailor MitraClip device choice to complex anatomy NTR, XTR, NTRW, XTRWCase studies Gagan Singh, MD.mp4
TRANSCATHETER MITRAL VALVE REPAIR REPLACEMENT – The Carillon device technique and outcomes Steve Goldberg, MD.mp4
TRANSCATHETER MITRAL VALVE REPAIR REPLACEMENT – The Pascal device technique and outcomes Charles Davidson, MD.mp4
TRANSCATHETER MITRAL VALVE REPAIR REPLACEMENT – TMVR – valve-in-valve patient selection, device sizing, and deployment technique Case studies Tarun Chakravarty, MD.mp4
TRANSCATHETER MITRAL VALVE REPAIR REPLACEMENT – Trans-septal puncture technologies and techniques Case studies Samir Kapadia, MD.mp4
TRANSCATHETER MITRAL VALVE REPAIR REPLACEMENT – Trans-septal puncture technologies and techniquesCase studies Samir Kapadia, MD.mp4
TRANSCATHETER TRICUSPID VALVE REPAIR – ICE is an ideal intra procedure imaging modality for Tricuspid repair Case studies Mohamad Alkhouli, MD.mp4
TRANSCATHETER TRICUSPID VALVE REPAIR – Transcatheter tricuspid valve repair (TriClip) Patient selection, imaging, and outcomes studies Samir Kapadia, MD.mp4
TRANSCATHETER TRICUSPID VALVE REPAIR – Tricuspid annuloplasty (The Cardioband) What have we learned so far Patient selection, imaging, and outcomes Case studies C.mp4
TRANSCATHETER TRICUSPID VALVE REPAIR – Tricuspid valve replacement Repair pipeline Azeem Latib, MD.mp4
UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE – Case conclusion Ramzan Zakir, MD.mp4
UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE – Case introduction A patient with left main coronary artery disease and low anatomic complexity Ramzan Zakir, MD.mp4
UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE – In the aftermath of the EXCEL trial PCI is preferable to CABG! Gregg Stone, MD,.mp4
UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE – In the aftermath of the NOBEL trial CABG is preferable to PCI! Steven Bailey, MD.mp4
UNSETTLED TAVR TOPICS – Balloon expandable vs. self expandable valves competitive or complimentary platforms Azeem Latib, MD.mp4
UNSETTLED TAVR TOPICS – Cerebral protection with TAVR State of the evidence Samir Kapadia, MD.mp4
UNSETTLED TAVR TOPICS – TAVR for aortic regurgitation Tips $ TricksCase studies Raj Makkar, MD.mp4
UNSETTLED TAVR TOPICS – When transfemoral access is not an option what’s your 2nd and 3rd access choiceCase studies Ron Waksman, MD.mp4